Literature DB >> 8682964

Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival.

V Sigurdsson1, J Toonstra, M Hezemans-Boer, W A van Vloten.   

Abstract

BACKGROUND: Erythroderma may result from different causes. There have been no publications on this subject with special emphasis on survival.
OBJECTIVE: The aim of the study was to determine the cause of the erythroderma and the prognosis of these patients.
METHODS: Clinical and follow-up data from 102 patients with erythroderma were analyzed. We estimated survival of patients with erythroderma, from causes other than Sézary syndrome, mycosis fungoides, or leukemia cutis. The survival was compared with that of an age-matched control group of the general population.
RESULTS: The main cause of erythroderma was exacerbation of a preexisting dermatosis (53%). Drug reactions were rarely the cause (5%). A high proportion of the patients had chronic actinic dermatitis/actinic reticuloid (12%). Survival of men with erythroderma was significantly lower than that of the general population.
CONCLUSION: Men with erythroderma, from causes other than Sézary syndrome, mycosis fungoides, or leukemia cutis, have a lower survival than men in the general population.

Entities:  

Mesh:

Year:  1996        PMID: 8682964     DOI: 10.1016/s0190-9622(96)90496-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  14 in total

1.  Dermatologic emergencies.

Authors:  Anatoli Freiman; Daniel Borsuk; Denis Sasseville
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

Review 2.  Dermacase. Erythroderma secondary to cutanous T-cell lymphoma.

Authors:  Irina Turchin; Benjamin Barankin
Journal:  Can Fam Physician       Date:  2005-07       Impact factor: 3.275

Review 3.  Neonatal erythroderma: differential diagnosis and management of the "red baby".

Authors:  P H Hoeger; J I Harper
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

4.  Erythroderma: a clinical study of 97 cases.

Authors:  Maryam Akhyani; Zahra S Ghodsi; Siavash Toosi; Hossein Dabbaghian
Journal:  BMC Dermatol       Date:  2005-05-09

Review 5.  [Paraneoplasms of the skin].

Authors:  C Gießen-Jung; A Wollenberg; M Reinholz
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

6.  Erythroderma. A clinical and etiological study of 103 patients.

Authors:  Artur César; Maria Cruz; Alberto Mota; Filomena Azevedo
Journal:  J Dermatol Case Rep       Date:  2016-03-31

Review 7.  Cutaneous Drug Reactions in the Elderly.

Authors:  James W S Young; Neil H Shear
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 4.271

8.  Clinico-etiological study of 30 erythroderma cases from tertiary center in South India.

Authors:  Manjunath Hulmani; B Nandakishore; M Ramesh Bhat; D Sukumar; Jacintha Martis; Ganesh Kamath; M K Srinath
Journal:  Indian Dermatol Online J       Date:  2014-01

9.  Erythroderma: review of a potentially life-threatening dermatosis.

Authors:  Cynthia Okoduwa; W C Lambert; R A Schwartz; E Kubeyinje; A Eitokpah; Smeeta Sinha; W Chen
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.

Authors:  Bruce E Strober; Jennifer Clay Cather; David Cohen; Jeffrey J Crowley; Kenneth B Gordon; Alice B Gottlieb; Arthur F Kavanaugh; Neil J Korman; Gerald G Krueger; Craig L Leonardi; Sergio Schwartzman; Jeffrey M Sobell; Gary E Solomon; Melodie Young
Journal:  Dermatol Ther (Heidelb)       Date:  2012-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.